Perimyocarditis following first dose of the mRNA-1273 SARS-CoV-2 (Moderna) vaccine in a healthy young male: a case report.

Ammar A HasnieUsman A HasnieNirav PatelMuhammad U AzizMin XieSteven G LloydSumanth D Prabhu

Published in: BMC cardiovascular disorders (2021)

We present a case of perimyocarditis that was temporally related to COVID-19 mRNA vaccination in an young male with prior COVID-19 infection but otherwise healthy. Our case report highlights an albeit rare but important adverse event for clinicians to be aware of. It also suggests a possible mechanism for the development of myocardial injury in our patient.

Keyphrases

sars cov
case report
respiratory syndrome coronavirus
middle aged
coronavirus disease
binding protein
palliative care
adverse drug